News Two new drugs added to WHO list of COVID-19 therapies A World Health Organization (WHO) panel has given the green light to two new drugs to treat COVID-19.
Views & Analysis Innovation and access: Improving Europe’s pharmaceutical reg... EMA “lags behind” other international regulators when it comes to approval timelines, finds EFPIA analysis.
Market Access Are we measuring what matters most on uptake to medicines in... In the second of a two-part series, Leela Barham argues that whilst international comparisons of uptake are useful, there could be more to gain from looking at more medicines and their upta
Market Access Getting better at measuring international uptake of medicine... In part one of a two-piece series, Leela Barham looks at whether we are getting better at measuring international uptake of medicines.
Partner Content Partner Content Patient and market insights from leading KOLs and life scien... Insights from leading KOLs in new Dermatology eBook
Sales & Marketing Sustained healthcare systems need sustainable pharma busines... COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing.
News Precision Neuro breaks new ground in BCI technology Precision Neuroscience has shown that people can control electronic devices with thought alone, without a need for electrodes implanted in the brain.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
